The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
ulipristal acetate · Powder
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 30 mg · Tablet · #1 blister pack/carton / 1 tablet in 1 blister pack
What changed in the last 90 days
Every detected change for ulipristal acetate, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- EllaAug 19, 2026Price upNADAC $37.09168 → $37.1002 per unit (+0.02%)
- EllaAug 5, 2026Mfr exitedHra Pharma America, Inc. · ulipristal acetate
- EllaJul 24, 2026Mfr enteredPMI Branded Pharmaceuticals, Inc. · ulipristal acetate
- EllaJul 24, 2026Product updatelabeler name: HRA PHARMA AMERICA, INC. → PMI Branded Pharmaceuticals, Inc.
- EllaJul 22, 2026Price downNADAC $37.09444 → $37.09168 per unit (-0.01%)
Common questions
- Is Ulipristal acetate in shortage right now?
- No. FDA does not currently list Ulipristal acetate in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Ulipristal acetate?
- 3 companies have marketed Ulipristal acetate in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Ulipristal acetate cost?
- The typical pharmacy pays about $37.10 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.